Evidence map›Paper›PMID 28739801›Full record

ArticleThe Journal of biological chemistry2017

Sustained

Ee Phie Tan, Steven R McGreal, Stefan Graw, Robert Tessman, Scott J Koppel, Pramod Dhakal, Zhen Zhang, Miranda Machacek, Natasha E Zachara, Devin C Koestler and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. TargetingbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Coupling of glucose metabolism with mitophagy via O-GlcNAcylation of PINK1.International journal of biological sciences · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Mitochondria in Alzheimer's Disease Pathogenesis.Life (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Ee Phie TanFrom the Departments of Biochemistry and Molecular Biology.
Steven R McGrealPharmacology, Toxicology and Therapeutics.
Stefan GrawBiostatistics.
Robert TessmanPharmacology, Toxicology and Therapeutics.
Scott J KoppelMolecular and Integrative Physiology.
Pramod DhakalPathology and Laboratory Medicine, and.
Zhen ZhangFrom the Departments of Biochemistry and Molecular Biology.
Miranda MachacekFrom the Departments of Biochemistry and Molecular Biology.
Natasha E Zacharathe Department of Biological Chemistry, The Johns Hopkins University of Medicine, Baltimore, Maryland 21205.
Devin C KoestlerBiostatistics.
Kenneth R PetersonFrom the Departments of Biochemistry and Molecular Biology.
John P ThyfaultPathology and Laboratory Medicine, and.
Russell H SwerdlowNeurology, University of Kansas Medical Center and.
Partha KrishnamurthyPharmacology, Toxicology and Therapeutics.
Luciano DiTacchioPharmacology, Toxicology and Therapeutics.
Udayan AptePharmacology, Toxicology and Therapeutics.
Chad SlawsonFrom the Departments of Biochemistry and Molecular Biology, cslawson@kumc.edu.
Emory University Hospital · USCancer Research And Biostatistics · USUniversity of Kansas · USJohns Hopkins Medicine · USLaboratoire d’immunologie intégrative du cancer · FRUniversity of Kansas Medical Center · US

Funding

University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ABRAHAMSON, DALE R · 2012 to 2016
$10.9M
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3M
Kansas University Training Program in Neurological and Rehabilitation SciencesT32HD057850 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jacob J. Sosnoff · 2009 to 2026
$3.4M
Mechanisms of Liver Regeneration After Acetaminophen-Induced Acute Liver FailureR01DK098414 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI APTE, UDAYAN · 2013 to 2023
$3.0M
Regulation of Globin Gene Switching by O-GlcNAc Post-Translational ModificationR01DK100595 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI PETERSON, KENNETH R, SLAWSON, CHAD ERIC · 2014 to 2016
$788k
JEOL JEM-1400 Transmission Electron Microscope with AMT-XR611M Digital Camera SysS10RR027564 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ABRAHAMSON, DALE R · 2010 to 2010
$418k
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosisI01BX002567 · VA · KANSAS CITY VA MEDICAL CENTER · PI THYFAULT, JOHN P · 2015 to 2025
–
BLRD VA I01 BX002567NCRR NIH HHS S10 RR027564NIA NIH HHS P30 AG035982NICHD NIH HHS T32 HD057850NIDDK NIH HHS R01 DK098414NIDDK NIH HHS R01 DK100595NIGMS NIH HHS P20 GM104936NIGMS NIH HHS P30 GM103326
6 · The paper itself

Abstract

Dysfunctional mitochondria and generation of reactive oxygen species (ROS) promote chronic diseases, which have spurred interest in the molecular mechanisms underlying these conditions. Previously, we have demonstrated that disruption of post-translational modification of proteins with β-linked

Indexed as

Energy MetabolismAcetylglucosamineAnimalsbeta-N-AcetylhexosaminidasesGlycosylationHumansMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaN-AcetylglucosaminyltransferasesTumor Cells, CulturedAcetylglucosaminebeta-N-Acetylhexosaminidaseshexosaminidase CN-AcetylglucosaminyltransferasesO-GlcNAc transferasebioenergeticsmitochondrianuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2)O-GlcNAcaseO-GlcNAcylationOGTreactive oxygen species (ROS)

Identifiers

PMID28739801
PMCPMC5592672
OpenAlexW2737043580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.